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1. Introduction
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver in humans
[1]. It is the fifth most common cancer in men (523,000 cases per year, 7.9% of all cancers) and
the seventh among women (226,000 cases per year, 3.7% of all cancers) [2], with over a half of
million new cases diagnosed annually. It is the second leading cause of the cancer related
mortality in the world [3,4,5] and its prevalence differs according to geographic location,
gender, age and ethnicity [6].
In general, the distribution of HCC cases presents great geographic variation, with higher
incidence  in  Easter  Asia  and sub-Saharan  Africa  where  infection  with  hepatitis  B  virus
(HBV) is endemic with rates of over 20 per 100,000 individuals. Mediterranean countries
such as Italy, Spain and Greece have intermediate rates of 10 to 20 per 100,000 individu‐
als. The North and South America have a relatively low incidence (< 5 per 100,000 individ‐
uals) [4], although a rising incidence was observed in the USA, probably associated with
the rise in hepatitis C virus (HCV) infection. Recent decreases in the incidence of HCC were
reported  among  Chinese  populations  in  Hong  Kong,  Shangai  and  Singapore;  the  inci‐
dence in Japan is also decreasing [3].
In Brazil, there are few reports on the prevalence of HCC [7]. It was suggested that the
prevalence was considered low according to epidemiologic and retrospective studies [8]. In
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1997, Brazilian researchers showed that HVB was the most common cause of liver disease in
patients with HCC [9]. After that, another survey demonstrated that in Southeastern and
Southern Brazil, HCV accounted for over 55% of cases. In the Northeast and North, HCV
accounted for less than 50% and HBV accounted for 22-25% of cases; hepatitis B was more
prevalent in the Northern than in the Southern regions [10].
The development of HCC has been attributed to several risk factors. In general, chronic viral
infection with HBV and HCV is considered the major cause of HCC in 75-80% of cases [1],
although HBV is globally considered the leading risk factor responsible for 50% of cases [11].
Furthermore, cirrhosis [12], exposure to the carcinogenic fungal aflatoxin B1 [13], inherited
diseases [14], Wilson’s disease [15] and heavy alcohol consumption [16] are also risk factors
attributed to its development. Recently, upcoming risk factors for HCC include obesity,
diabetes and related nonalcoholic fatty liver disease [3].
In 1994, researchers described the infectious agent Helicobacter (H.) hepaticus and its role in
causing active hepatitis and associated liver tumors in mice [17]. Since then, several studies
related to H. hepaticus experimental infection have demonstrated that this bacterium may
induce a strong inflammatory change in the liver leading to HCC. Considering that H. pylori
was classified as a class I carcinogen [18] and Helicobacter spp. DNA was detected in hepatic
tissue  from  patients  with  different  hepatobiliary  diseases,  it  has  been  proposed  that  in
humans,  as  in  animals,  Helicobacter  spp.  may  also  colonize  and  induce  chronic  hepatic
diseases mainly HCC.
In fact, studies related to the possible association between H. pylori and hepatobiliary diseases
have been developed since 1998, when Helicobacter DNA was identified in Chilean patients
with chronic cholecystitis [19]. After that, a variety of researches have been conducted to verify
the role of H. pylori in the development of HCC [20, 21, 22, 23, 24, 25, 26 e 27]. Considering the
role of chronic inflammation and infection in the development of cancer, in the case of HCC,
future studies should be performed to verify the role of Helicobacter infection in the liver
pathophisiology [28]. However, whether this bacterium causes liver tumor or acts as a cofactor
in the process of carcinogenesis needs to be confirmed.
The mechanism by which H. pylori colonizes the human liver is not totally enlightened. The
H. pylori DNA detected in the liver tissue may result from bacterial translocation from the
stomach into the blood through the portal system, especially in the later stages of chronic liver
disease when portal hypertension occurs [1, 29, 30]. In addition, the bacteria may reach the
liver by phagocytes and macrophages or circulating retrograde transfer from the duodenum
[31]. However, the studies involving the growth of H. pylori from the HCC liver reinforce the
bacterial colonization ruling out the possibility of retrograde contamination [32, 33]. Addi‐
tionally, no other bacteria from the digestive tract are associated with human hepatocarcino‐
genesis [23, 34].
Several researchers have suggested that H. pylori may damage hepatocytes in vitro by a
cytopathic effect in a liver and HCC cell lines [35, 36]. Furthermore, it was demonstrated in a
HCC cell line (Huh7) that an inoculum of H. pylori was able to adhere and internalize into
hepatocytes and this result was also dependent on virulence factors of bacteria [37]. Proteomic
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analysis of human hepatic cell line (HepG2) co-cultured with H. pylori have revealed that
bacteria may exert the pathological effect on HepG2 cells by up-regulating the expression of
some proteins enrolled in transcription regulation, signal transduction and metabolism [38].
In most pathology laboratories, archives of formalin-fixed paraffin-embedded (FFPE) tissues
represent the only tissue specimens available for routine diagnostics. A major advantage of
such archives is that long-term clinical data is often available [39]. Furthermore, another benefit
of using FFPE tissues is that they are the easiest to store and transport [40]. Because of this,
FFPE tissues have been used in PCR-based studies related to cancer research, genetics,
infectious diseases and molecular epidemiology [41]. Additionally, the use of FFPE tissue also
allows employing modern transcriptomic and epigenomic methods with nucleic acids [39].
However, isolating high-quality genomic DNA from FFPE sections remains a challenge for
researchers. Formalin is the most commonly used tissue fixative worldwide because it offers
the best compromise between cost, practicality and morphological fixative properties [39, 42].
However, the fixation of tissue in formalin leads to extensive protein-DNA cross-linking of all
tissue components and nucleic acids isolated from these specimens are highly fragmented [43].
This is particularly troublesome when long DNA regions are amplified, old paraffin blocks
are used or fixation time is over three days [41, 44]. Because of this, FFPE tissue requires special
protocols in order to extract small amounts of DNA suitable for amplification [45]. Neverthe‐
less, methods of DNA extraction from FFPE tissue are generally laborious and time consuming.
Although studies on the role of the H. pylori in the development of HCC were more frequent
in the last decade [46], most of them presents a prospective nature. This probably occurs
because the retrospective studies frequently employ FFPE liver tissue and DNA extraction is
a limiting factor in this type of sample. However, several researchers have detected H. pylori
and its virulence factors (vacA genes and 26 kDa) in paraffin embedded liver samples [21, 27,
34, 47, 48].
Laser capture microdissection (LCM) is a technique that has recently become available for
isolation of individual or groups of cells from a heterogeneous tissue sections by microscopic
visualization. The technique was first described in 1996 by researchers of the National
Institutes of Health (NIH) in Bethesda, MD [49] and allows the isolation of cells reducing the
interference from nontarget cell population. The method allows selection of unmixed starting
material for DNA, RNA or protein extraction for further downstream analyses [50].
The LCM system is based on an inverted light microscope fitted with a laser device to facilitate
the visualization and procurement of cells [51]. The PALM MicroBeam System (Carl Zeiss,
MicroImaging GmbH, Göottingen, Germany) was used in this study and it is based on the
Laser Microdissection and Pressure Catapulting technology. This system consists of an
inverted microscope with a motorized stage and a pulsed “cold” nitrogen ultra-violet (UV)
laser. The laser is focused through the objective lenses to a micron-sized spot diameter. The
narrow laser focal spot allows the ablation of the material while the surrounding tissue remains
fully intact. The microscope stage and UV laser are controlled by a PC, and a video camera
allows for tissue sections to be displayed on the PC screen. Cells or regions of interest are then
identified and manually delineated on the computer screen using the software program. The
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microscope is then instructed to collect delineated regions. The noncontact capture of homo‐
geneous tissue samples or individual cells is achieved by means of catapulting using PALM’s
patented Laser Pressure Catapulting technology. With the same laser, the separated cells, or
the selected tissue area, can be directly catapulted into the eppendorf cap containing a
depressed lid [52, 53]. The Figure 1 shows the LCM technology employed in this study.
LCM has been used in a wide variety of applications, including pathology [54, 55], organ
transplantation [56, 57], gene expression [52, 58] and molecular characterization of cancer cells
[59, 60, 61]. LCM is compatible with most stains and tissue preservation techniques including
frozen sections, FFPE tissues, cytology preparations and cultured cells [52, 62]. Because of its
high precision and accuracy LCM has been successfully employed to isolation of bacterial cells
in FFPE tissues including H. pylori [48, 61, 62, 64, 65].
 (a) (b) 
) 
Figure 1. Images of LCM technology used in the study. In A is represented the complete PALM MicroBeam system. In B
is illustrated the path of the laser beam passing through the objective lens to reach the tissue slice and the catapulting
process for capturing the cells of interest into the Eppendorf cap. Source of the images: www.zeiss.de.
2. Clinical samples, methods and results
2.1. Clinical samples
This study was carried out utilizing six cases of FFPE liver tissue from patients with HCC
from Department of Anatomic Pathology, Faculty of Medical Sciences, State University of
Campinas (UNICAMP), Campinas, São Paulo, Brazil. The mean ages of patients was 56.0
years, with 4 male cases (66,6%) and 2 female cases (33,4%). All the fragments of liver were
obtained  during  hepatic  surgery  (either  transplantation  or  partial  hepatectomy).  These
samples were H. pylori  positive previously detected by polymerase chain reaction (PCR)
with H. pylori specific 16S rRNA primers [27]. The selection criteria for the paraffin blocks
included specimens archived for 5 years (2008 to 2012). The present study was approved
by the Ethics Committee of the Faculty of Medical Sciences, UNICAMP (CEP 616/2009).
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2.2. Methods
2.2.1. Tissue preparation for LCM
Six H. pylori positive samples were cut into 10µm-thick sections and mounted on 0.17mm PEN
membrane-covered slides (Carl Zeiss, MicroImaging GmbH, Göttingen, Germany). After
slicing, the sections were placed at 60°C for 30 minutes, then deparaffinized in 3 xylene baths
(3x1min), rehydrated in decreasing alcohols (100%, 95% e 70%, each for 30 seconds) and
washed for 30 seconds in tap water. Further, the routine staining with carbol fuchsin was
performed [66]. At this step the sections have remained in the dye for at most 15 seconds. The
stained sections were observed under the microscope for the identification of bacteria.
2.2.2. Bacterial microdissection
Stained bacteria were microdissected using a PALM MicroBeam system (Carl Zeiss, MicroI‐
maging GmbH, Göttingen, Germany) (Figure 1A). The areas with target bacteria were traced
around and microdissected together with the pieces of thin membrane by laser microbeam
and then ejected into the Eppendorf tube cap by a single laser shot (Figure 1B). The tube was
stored at -80°C until DNA extraction.
2.2.3. DNA extraction
After microdissection, the cap was inserted into an Eppendorf tube containing 100µl digestion
buffer, prepared with 10mM Tris-HCl (pH 8.0), 1mM EDTA, 1% Tween 20 and 0.3% proteinase
K. After that, samples remained in a water bath at 56°C for 3 hours and the tube was heated
to 95°C for 5 min to inactivate proteinase K. The crude lysate was directly employed as template
for PCR. All of these procedures were previously described with minor modifications [48].
2.2.4. PCR amplification
The samples were further amplified by PCR using H. pylori 16S rRNA primers. The sequence
of the sense primer (JW21) was 5’-GCGACCTGCTGGAACATTAC-3’(position 691-710) and
the antisense primer (JW22) was 5’-CGTTAGCTCCATTACTGGAGA-3’ (position 829-809)
and they amplified a product of approximately 129bp [27]. Briefly, 1µl of DNA extracted
was added to 25µl PCR mix containing deoxynucleoside triphosphates (dNTPs) at concen‐
trations of  200 µM each,  2.0µl of  25mM MgCl2,  0.25 µl  of  GoTaq Hot Start  Polymerase
(Promega Corp., Madison, WI, USA), 4.0 µl of 5X GoTaq Flexi Buffer (supplied with the
enzyme) and 20 pmol each primer (Life Technologies, Carlsbed, CA, USA). Amplification
reactions included an initial 2-minute denaturation step at 94ºC, followed by 40 cycles of
30 seconds at 94ºC, 30 seconds at 55ºC and 45 seconds at 72ºC. A final extension step for 7
minutes at 72ºC was performed. The DNA extracted from H. pylori from FFPE gastric tissue
was used as positive control and distilled water in place of the DNA samples was used as
negative control for PCR assays.
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2.2.5. Detection of PCR products
For analysis of the amplified products, 5µl of the amplicons were put on 1,5% agarose gels
containing 1µg of ethidium bromide per ml. The amplicons were visualized by UV transillu‐
mination.
2.2.6. Sequence analysis
The 16S rRNA amplicons were further identified by sequence analysis using ABI Prism Dye
Terminator sequencing kit with AmpliTaq DNA polymerase and the ABI 3500xL Sequencer
(Applied Biosystems, Foster City, CA, USA). Sequence comparison was then carried out using
the Blast program and GenBank databases.
2.3. Results
Analyzing the tissue sections stained with carbol fuchsin, we visualized microorganisms
resembling H. pylori mainly in hepatic sinus from HCC samples. The number of cocci was
greater than of bacilli (Figure 3).
Our PCR results showed that all six microdissected samples were positive for 16S rRNA gene
(Figure 2) and showed 98% similarity to H. pylori 16S rRNA gene by sequence analysis
(GeneBank accession number CP003419.1) (Figure 4).
 MM 3 1 2 4 5 PC NC 
Figure 2. Results of amplification of H. pylori 16S rRNA gene. 1, 2 and 5 are positive samples; 3 and 4 are negative
samples. MM: molecular marker, PC: positive control and NC: negative control.
Trends in Helicobacter pylori Infection232
Figure 3. Optical microscopy of FFPE liver fragments of HCC patients with PCR-positive H. pylori 16S rRNA and stained
with carbol fuchsin. In (A) and (C) bacteria are represented within sinusoid (arrows) before microdissection (magnifica‐
tion: 610X). In (B) and (D) the same samples are represented after bacterial microdissection (magnification: 610X).
Figure 4. Electropherogram sequence of H. pylori 16S rRNA gene and alignment results of the BLAST databases.




The results described here confirm the identification of H. pylori in FFPE liver tissue from
patients with HCC. Although specific primers were used for amplification of the H. pylori
16S rRNA gene, we cannot exclude the possibility of cross-reaction of these primers with
other Helicobacter spp [65].
Considering the difficulty of DNA extraction from paraffin embedded samples, the use of LCM
simplified the achievement of specific DNA because the DNA extraction process was reduced
to a single digestion step of bacterial cells without further purification. Consequently, the crude
lysate was used directly as template for PCR amplification. This is particularly advantageous
when compared to traditional methods of DNA extraction that are generally laborious, toxic
and time consuming [67].
Another advantage of using LCM is that it allowed the exact location of H. pylori in the liver,
since bacteria were mainly found in the peritumoral tissue. Considering that our samples
presented tumoral and peritumoral tissue in the same paraffin block, the technique was highly
effective for obtaining a target bacterial population within a selected area in the HCC tissue.
This is very important when we consider that the necrotic state and nuclease content of tissues
may influence in recovering intact DNA specially when performing traditional methods for
DNA extraction [68].
Furthermore, LCM was useful to reduce the interference from nontarget cell population
considering that bacteria were found in small quantities in the liver tissue (Figure 3). In relation
to nontarget cell population, it is important to consider that the major obstacle in the analysis
of tumoral tissue is that it is composed by different cell types including stroma and inflam‐
matory cells [69, 70, 71] and there is a potential dilution effect of the larger quantities of
nontarget DNA found in whole tissue sections [64]. Thus, the employment of LCM was very
efficient in isolating H. pylori despite of the reduced bacterial quantity in the HCC tissue.
In summary, we suggest that LCM can be extensively applied for identification of H. pylori in
FFPE liver tissue. Further studies will be performed in order to amplify virulence genes of
bacteria as well as to isolate H. pylori from other tissues using LCM technique.
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